NT5E and glioblastoma: Additionally, TIGIT.SynNotch.aCD73 iNK cells demonstrated superior lysis against CD155 + CD73 + GBM10 and U87-MG targets, but not CD155 + CD73- SJ-GBM targets (Fig. 3G-I).